Welcome to LookChem.com Sign In|Join Free
  • or
N,N'-DIACETYLSULFANILAMIDE is a chemical compound derived from sulfanilamide, a common antibiotic. It is synthesized by acetylating the amine groups of sulfanilamide, resulting in a compound with two acetyl groups attached to the nitrogen atoms. This modification is commonly used to increase the solubility and stability of the original compound. N,N'-DIACETYLSULFANILAMIDE has been studied for its potential as a drug and has been found to have antimicrobial properties. It is also used in various chemical reactions and as a reagent in organic synthesis. N,N'-DIACETYLSULFANILAMIDE is of interest to researchers and pharmaceutical companies for its potential applications in medicine and industry.

5626-90-4

Post Buying Request

5626-90-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5626-90-4 Usage

Uses

Used in Pharmaceutical Industry:
N,N'-DIACETYLSULFANILAMIDE is used as a potential drug candidate for its antimicrobial properties. It can be employed to combat various types of infections caused by bacteria.
Used in Chemical Synthesis:
N,N'-DIACETYLSULFANILAMIDE is used as a reagent in organic synthesis, facilitating various chemical reactions and contributing to the production of other compounds.
Used in Research and Development:
N,N'-DIACETYLSULFANILAMIDE is used in research and development for its potential applications in medicine and industry. It is being studied to explore its properties and possible uses in the development of new drugs and chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 5626-90-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,2 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5626-90:
(6*5)+(5*6)+(4*2)+(3*6)+(2*9)+(1*0)=104
104 % 10 = 4
So 5626-90-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O4S/c1-7(13)11-9-3-5-10(6-4-9)17(15,16)12-8(2)14/h3-6H,1-2H3,(H,11,13)(H,12,14)

5626-90-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[4-(acetylsulfamoyl)phenyl]acetamide

1.2 Other means of identification

Product number -
Other names N,N-DIACETYLSULFANILAMIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5626-90-4 SDS

5626-90-4Synthetic route

acetic anhydride
108-24-7

acetic anhydride

p-acetylaminobenzenesulfonamide
121-61-9

p-acetylaminobenzenesulfonamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
With magnetic composite Fe3O4 Diatomite earth In tetrahydrofuran at 50℃; for 1h; Catalytic behavior; Reagent/catalyst; Temperature; Time; Solvent;93%
sodium acetate
127-09-3

sodium acetate

sulfanilamide
63-74-1

sulfanilamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
With acetic anhydride for 4h; Reflux;77%
acetic anhydride
108-24-7

acetic anhydride

sulfanilamide
63-74-1

sulfanilamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
for 8h; Reflux;70%
With pyridine
acetic anhydride
108-24-7

acetic anhydride

sulfanilamide
63-74-1

sulfanilamide

A

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

B

sulphaacetamide
144-80-9

sulphaacetamide

Conditions
ConditionsYield
With sodium hydroxide In water at 75 - 85℃; for 0.25h; Acylation;A 13%
B 69%
acetic anhydride
108-24-7

acetic anhydride

sulphaacetamide
144-80-9

sulphaacetamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
With pyridine for 1h; Reflux;14.2%
N-mandeloyl-sulfanilic acid amide
4361-52-8

N-mandeloyl-sulfanilic acid amide

acetic anhydride
108-24-7

acetic anhydride

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
at 170℃;
acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

sulfanilamide
63-74-1

sulfanilamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

acetyl chloride
75-36-5

acetyl chloride

p-acetylaminobenzenesulfonamide
121-61-9

p-acetylaminobenzenesulfonamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

Conditions
ConditionsYield
With pyridine
Phenyl acetate
122-79-2

Phenyl acetate

p-acetylaminobenzenesulfonamide
121-61-9

p-acetylaminobenzenesulfonamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

N-methyl-N-phenylformamide
93-61-8

N-methyl-N-phenylformamide

N-[4-({(E)-[methyl(phenyl)amino]methylidene}sulfamoyl)phenyl]acetamide

N-[4-({(E)-[methyl(phenyl)amino]methylidene}sulfamoyl)phenyl]acetamide

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane at 0 - 20℃; for 4h;83%
N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

sulphaacetamide
144-80-9

sulphaacetamide

Conditions
ConditionsYield
With sodium hydroxide for 2h; Reflux;30%
With sodium hydroxide
With potassium hydroxide
N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

ethanolic KOH-solution

ethanolic KOH-solution

sulphaacetamide
144-80-9

sulphaacetamide

N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

p-acetylaminobenzenesulfonamide
121-61-9

p-acetylaminobenzenesulfonamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: oxalyl dichloride / dichloromethane / 4 h / 0 - 20 °C
2: hydrazine hydrate / ethanol / 1.5 h / 20 °C
View Scheme
N-acetyl-4-(acetamido)benzenesulfonamide
5626-90-4

N-acetyl-4-(acetamido)benzenesulfonamide

C11H13ClN2O4S

C11H13ClN2O4S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / 2 h / Reflux
2: potassium carbonate / water / 2 h / 20 °C / Cooling with ice
View Scheme

5626-90-4Relevant academic research and scientific papers

Inhibition of carbonic anhydrase II by sulfonamide derivatives

Li, W.,Xuan, G. S.,Zhan, J. H.,Zhang, A. M.,Zheng, K.

, p. 412 - 415 (2021/11/22)

A series of sulfonamide derivatives were synthesized, and the enzyme inhibitory activity of the synthesized compounds on carbonic anhydrase II was evaluated. Through molecular docking studies, it was found that compounds 1b, 1e, 2a, 2b, 3a have a strong binding affinity to carbonic anhydrase II. The IC50 values of the four compounds 1e, 2b, 3a, and 3b were lower than that of the positive control drug acetazolamide. What’s more, the compounds had a high inhibitory activity for A549 lung cancer cell growth, among them, 1e and 3a could inhibit both carbonic anhydrase II and lung cancer cell proliferation.

Structural, spectroscopic and nonlinear optical properties of sulfonamide derivatives; experimental and theoretical study

Arshad, Muhammad Nadeem,Faidallah, Hassan M.,Asiri, Abdullah M.,Kosar, Naveen,Mahmood, Tariq

, (2019/11/26)

Nonlinear optical (NLO) materials have broad range applications in the field of optoelectronic devices. Nowadays great interest has been developed for synthesizing the compounds having high NLO response. Herein we are reporting the structural, spectroscopic and NLO properties of two, structurally simple sulfonamide derivatives. Both compounds are synthesized in respectable yields, characterized by using NMR (1H and 13C), FT-IR and UV–vis spectroscopic techniques. X-ray diffraction analysis confirmed the final structures. Density functional theory (DFT) at B3LYP/6-31G(d,p) method are performed for validation of experimental data (X-ray as well as spectroscopic data). Absorption studies of both compounds are performed by using TD-DFT method. Coefficients of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) of both compounds reflect the high stability. First hyperpolarizability (βo), polarizability (αo) and dipole moment (μ) analyses calculated at LC-BLYP method revealed that both derivatives have reasonable nonlinear optical (NLO) response. The static, dc-Kerr effect and electric field-induced second harmonic generation (ESHG) hyperpolarizability co-efficient are also studied for refractive index (n2) calculation of both sulfonamides, to further observe their NLO response.

Catalytic activity of magnetic Fe3O4@Diatomite earth and acetic acid for the N-acylation of sulfonamides

Ghasemi, Mohammad Hadi,Kowsari, Elaheh,Hosseini, Seyed Kiumars

supporting information, p. 387 - 391 (2016/01/12)

The Br?nsted and Lewis acidic promoted N-acylation of sulfonamides with acetic anhydride or benzoyl chloride has been achieved using glacial acetic acid and magnetic Fe3O4@Diatomite earth. Use of acetic acid as solvent omits the need for organic bases and permits the isolation of products by filtration and precipitation. Additionally, the magnetic composite Fe3O4@Diatomite acts as a conjugate proton super acid, enabling the acylation of sulfonamide compounds.

Compound capable of inhibiting activity of NEDD8 kinase as well as preparation method and pharmaceutical application of compound

-

Paragraph 0160; 0161; 0162, (2016/10/10)

The invention belongs to the field of medicines and in particular relates to a compound with the structure of a formula I, a stereomer of the compound or pharmaceutically acceptable salts of the compound as well as a preparation method of the compound and application of the compound to preparation of anti-tumor medicines. A pharmacological experiment result shows that the compound can be used for inhibiting the activity of NEDD8 kinase and has the inhibition effect on proliferation of a plurality of types of tumor cells, so that the compound can be used as an NEDD8 kinase activity inhibitor for preparing the anti-tumor medicines. The formula I is shown in the description.

Identification of a β1/β2-Specific Sulfonamide Proteasome Ligand by Crystallographic Screening

Beck, Philipp,Reboud-Ravaux, Michèle,Groll, Michael

supporting information, p. 11275 - 11278 (2016/07/06)

The proteasome represents a validated drug target for the treatment of cancer, however, new types of inhibitors are required to tackle the development of resistant tumors. Current fluorescence-based screening methods suffer from low sensitivity and are limited to the detection of ligands with conventional binding profiles. In response to these drawbacks, a crystallographic screening procedure for the discovery of agents with a novel mode of action was utilized. The optimized workflow was applied to the screening of a focused set of compounds, resulting in the discovery of a β1/β2-specific sulfonamide derivative that noncovalently binds between subunits β1 and β2. The binding pocket displays significant differences in size and polarity between the immuno- and constitutive proteasome. The identified ligand thus provides valuable insights for the future structure-based design of subtype-specific proteasome inhibitors.

Acylation of benzenesulfamides in alkaline solutions

Kotlyar,Gorodnyuk,Grigorash,Zlotskii

, p. 1653 - 1654 (2007/10/03)

Acylation of 4-aminobenzenesulfamide with acetic anhydride in aqueous sodium hydroxide was studied, and the main acylation products were determined.

Footprint Catalysis. II. Molecular Recognition of Footprint Catalytic Sites

Morihara, Kensaku,Nishihata, Emiko,Kojima, Mari,Miyake, Sayoko

, p. 3999 - 4004 (2007/10/02)

In order to investigate the molecular recognition capability of "footprint" catalytic sites, the affinities of nine "footprint" catalysts for eleven competitive inhibitors, closely related to template molecules, were estimated through the competitive inhibition constants, Ki .An examination of the affinity revealed that the recognition by "footprint" catalytic sites was so highly specific that it could recognize not only the whole, but also the partial, stuctures of the bound molecules.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5626-90-4